RGT 8.62% 26.5¢ argent biopharma limited

CannaGlobal Payment Due, page-215

  1. 13,812 Posts.
    lightbulb Created with Sketch. 2339

    Very intriguing article - predicts MXC will have 3% of the European market in 12 months (8 countries that support MM). Notice that did not include the potential Malta Enterprise production nor that the UK and other European countries are moving rapidly towards MM recognition and acceptance.


    Also, we have several posts regarding whether CannEpil has ever had trials - they have had at least one.


    “CannEpil’s formulation is supported by the results of a retrospective study of 74 patients with refractory epilepsy, which reported that 51 per cent of children with refractory epilepsy experienced at least a 50 per cent reduction in seizures when they were treated with a cannabis oil containing the same 20:1 CBD/THC ratio as CannEpil,” Edison noted.


 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.